DexCom

Oura is a Finnish company that specializes in the development of a smart wellness ring designed to monitor and track various biometric data related to health and well-being. The ring incorporates advanced sensors to measure key metrics such as heart rate, sleep cycles, and activity levels, providing users with insights into their physiological and behavioral responses to sleep, rest, and recovery. This data is accessible through the accompanying Oura application, which enables users to understand their overall health status and make informed lifestyle choices. Oura operates within the health and wellness industry, focusing on enhancing the user's understanding of their body and promoting better health outcomes.

Phenomix Sciences is a biotechnology company founded in 2017 and headquartered in New York, United States. It specializes in the fields of metabolomics and genomics, focusing on developing healthcare solutions for personalized management of chronic diseases. The company has created a data analysis platform aimed at precision medicinal research for obesity management, which features a novel blood test and an AI-driven algorithm. This platform classifies the unique pathophysiological phenotype of patients with obesity, providing healthcare centers with tools and services that enhance the efficacy of obesity management while also reducing side effects and overall costs.

Current Health Limited is a healthcare technology company based in Edinburgh, United Kingdom, that specializes in wearable devices for monitoring patient vitals. Founded in 2014 and originally known as Snap40 Limited, the company rebranded in December 2018. Current Health's devices are designed to measure critical health indicators such as oxygen saturation, respiration rate, pulse rate, temperature, motion, activity, and posture, enabling early identification of potential health issues. Their patient monitoring platform facilitates the management of patients at home by collecting and analyzing data to detect and predict health deterioration. This allows patients to share daily activities, report symptoms, and complete structured questionnaires, ultimately helping healthcare providers reduce risks and costs associated with patient care.

Beta Bionics is a biotechnology company focused on developing advanced solutions for diabetes management. Its flagship product, the iLet Bionic Pancreas System, is an integrated device designed to alleviate the burden of diabetes care. This system encompasses a dual-chamber infusion pump that delivers insulin and glucagon with precision and accuracy, autonomously calculating and administering doses to help patients maintain optimal blood sugar levels. The iLet has received breakthrough designation for all its configurations, including insulin-only, glucagon-only, and bihormonal, and it incorporates Zealand Pharma’s dasiglucagon, which is known for its stability in a ready-to-use aqueous solution. Through these innovations, Beta Bionics aims to improve the quality of life for individuals living with diabetes.

TypeZero Technologies LLC is a healthcare technology company based in Charlottesville, Virginia, focused on diabetes management solutions. Incorporated in 2013, it has developed the inControl Diabetes Management Platform, which includes an innovative smartphone-based artificial pancreas that automates insulin delivery, significantly reduces the risk of hypoglycemia, and improves blood glucose levels. Additionally, the platform features inControl Advice, a mobile advisory system that provides real-time recommendations for meal planning, basal rates, bolus calculations, and exercise decisions. TypeZero also offers inControl Cloud, a suite of cloud-based tools that enable real-time monitoring and notifications for caregivers and family members, as well as retrospective data analysis to identify treatment inefficiencies. As of August 2018, TypeZero operates as a subsidiary of DexCom, Inc.

Nintamed is a distribution company operating in Germany, Switzerland, and Austria, specializing in products for diabetes management. The company develops a continuous glucose monitoring system that enables patients to track their blood sugar levels effectively. Additionally, Nintamed produces pen needles designed for the administration of insulin, enhancing the convenience and comfort of diabetes care. Through its innovative products, Nintamed aims to improve the quality of life for individuals living with diabetes.

SweetSpot Diabetes Care is a health data company dedicated to enhancing diabetes management through effective data utilization. It specializes in transforming raw data from patient devices into comprehensive reports that serve researchers, healthcare providers, and patients alike. By facilitating the download and analysis of device data, SweetSpot simplifies the process for endocrinology clinics, enabling them to generate essential reports for doctors, nurses, and diabetes educators. This service alleviates the complexities associated with multiple data interfaces and formats, allowing healthcare providers to gain insights into patients' blood glucose levels, patterns, and fluctuations. Ultimately, SweetSpot aims to empower patients with self-service tools for data retrieval and management, improving overall diabetes care and enabling clinics to optimize their time and resources.